Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New antibiotic target could mean the end of pneumonia

10.12.2004


Scientists have found a “molecular Achilles heel” in the organism that causes pneumonia, providing a target for the development of a new class of antibiotics that could eventually eradicate the disease. Their report is scheduled to appear in the Dec. 28 edition of Biochemistry, a peer-reviewed journal of the American Chemical Society, the world’s largest scientific society.



“Streptococcus pneumoniae places an enormous burden on the welfare of humanity,” says Thomas Leyh, Ph.D., a professor of biochemistry at the Albert Einstein College of Medicine in New York and lead author of the paper. “Worldwide, the organism takes the lives of some 3,700 people daily, the majority of whom are children below the age of five.”

Decades of antibiotic use have produced drug-resistant strains of S. pneumoniae that are capable of evading even our so-called “last-line-of-defense” antibiotics, such as vancomycin. In the United States alone, the roughly 7 million annual cases of inner ear infections caused by this organism saddle the U.S. heath care system with an estimated $5 billion burden, Leyh says.


The virulence of S. pneumoniae requires a properly functioning channel called the isoprenoid biosynthetic pathway. Leyh and his colleagues have discovered that an intermediate in the pathway — diphosphomevalonate, or DPM — can inhibit the first enzyme, effectively shutting down the whole process. “If you switch this pathway off, the organism is in big trouble,” Leyh says. Without this channel, the normally pathogenic S. pneumoniae is unable to survive in mouse lungs and its virulence is severely attenuated.

“Remarkably, the human enzyme is not influenced by the inhibitor,” Leyh says. This means that S. pneumoniae in human lungs or blood should be inhibited without any negative effect on human metabolism.

DPM binds to its own “pocket” on the enzyme, and therefore cannot be dislodged by the enzyme’s natural substrates. Pharmaceutical companies consider such targets to be among the most important elements in deciding whether or not to pursue a problem, according to Leyh. “We recognize the need to work with a pharmaceutical partner to bring our basic research discovery to the bedside, and, hopefully, to cure this disease.”

The researchers plan to use DPM as a template for developing novel antibiotics to cure pneumonia and other streptococcal diseases, such as meningitis. “We consider DPM a very powerful lead compound,” Leyh continues. “It’s about as compelling as it can be at this stage.” Leyh’s lab is currently developing and testing five compounds based on the DPM template for their potential as new antibiotics.

The American Chemical Society is a nonprofit organization, chartered by the U.S. Congress, with a multidisciplinary membership of more than 159,000 chemists and chemical engineers. It publishes numerous scientific journals and databases, convenes major research conferences and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio. — Jason Gorss

Michael Bernstein | EurekAlert!
Further information:
http://www.acs.org

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>